LMDX实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (5 Apr 2024 @ 04:00):

Stats
今日成交量	120.55M
平均成交量	0.00
市值	249.63M
EPS	$0 ( 2024-03-19 )
下一个收益日期	( $0 ) 2024-05-14
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.0100
ATR14	$0.0140 (93.33%)

音量相关性

長: 0.04 (neutral)

短: -0.37 (neutral)

Signal:(34.365) Neutral

LumiraDx Limited 相关性

10 最正相关
RMRM	0.966
CRGE	0.948
BCAN	0.939
CNEY	0.93
ADMP	0.921
JWEL	0.918
CVAC	0.909
LGVN	0.908
RIDE	0.907
BROG	0.905

10 最负相关
KEQU	-0.945
RNLC	-0.931
FRG	-0.92
PTMN	-0.919
SGII	-0.905
IMPP	-0.902
KRUS	-0.901
INBKZ	-0.9
VMGA	-0.898
AEAE	-0.895

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

LumiraDx Limited 相关性 - 货币/商品

-0.80
( moderate negative )

-0.41
( neutral )

0.00
( neutral )

-0.45
( neutral )

0.83
( strong )

LumiraDx Limited 财务报表

Annual	2022
营收:	$254.48M
毛利润:	$-35.30M (-13.87 %)
EPS:	$-1.590

FY	2022
营收:	$254.48M
毛利润:	$-35.30M (-13.87 %)
EPS:	$-1.590

Financial Reports:

No articles found.

LumiraDx Limited

LumiraDx Limited operates as a point of care diagnostics company. The company focuses on transforming community-based healthcare by providing critical diagnostic information to healthcare providers. It manufactures and commercializes a diagnostic platform that supports various tests with lab comparable performance at the point of care. The company has approximately 30 tests on the market and in development covering infectious diseases, cardiovascular diseases, diabetes, and coagulation disorders, as well as a portfolio of COVID-19 testing solutions from the lab to point of need. Its diagnostic testing solutions are deployed by governments and healthcare institutions across laboratories, urgent care, physician offices, pharmacies, schools, and workplaces to screen, diagnose, and monitor wellness, as well as disease. The company was founded in 2014 and is headquartered in London, the United Kingdom.